行情

ALEC

ALEC

Alector
NASDAQ

实时行情|Nasdaq Last Sale

27.46
+0.05
+0.18%
交易中 12:55 02/27 EST
开盘
27.20
昨收
27.41
最高
27.89
最低
26.22
成交量
42.20万
成交额
--
52周最高
35.93
52周最低
13.64
市值
18.77亿
市盈率(TTM)
-18.2483
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ALEC价格均价为33.00,最高价位44.00,最低价为27.00。

EPS

ALEC 新闻

更多
  • Alector to Present at the Cowen 40th Annual Health Care Conference
  • GlobeNewswire · 3天前
  • Stifel likes Alector and Denali in premarket analyst action
  • Seeking Alpha - Article · 02/19 12:06
  • Stifel Nicolaus Initiates Coverage On Alector with Buy Rating, Announces $44 Price Target
  • Benzinga · 02/19 10:51
  • IPO Update: Passage Bio Finalizes $126 Million IPO Plan
  • Seeking Alpha - Article · 02/18 20:57

所属板块

生物技术和医学研究
-0.45%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

ALEC 简况

Alector, Inc. is a clinical-stage biopharmaceutical company focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologies that are drivers of degenerative brain disorders. The Company is developing therapies designed to simultaneously counteract these pathologies by restoring healthy immune function to the brain. The Company's platform leverages large scale human genetic datasets, advanced tools in bioinformatics and imaging, and insights into neurodegeneration and immunology to identify immune system. Its platform focuses on target selection, biomarker selection and patient selection. Its product portfolio includes AL001, AL101, Al002 and AL003. Its AL001 targets frontotemporal dementia carrying a progranulin (FTD-GRN).
展开

微牛提供Alector Inc(NASDAQ-ALEC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ALEC股票新闻,以帮助您做出投资决策。